Nanopath

We're hiring for a range of positions at Nanopath! Come join a company dedicated to commercializing an impactful technology to improve the health of women. Engineers! Operators! Product Managers!

The energy surrounding #womenshealth at #JPM2025 is truly remarkable. Today, let's introduce six impactful innovators funded by The National Institutes of Health, poised to revolutionize how we understand and treat various health conditions: - Bloomer Tech is utilizing a bra-like device to develop unique biomarkers for female cardiovascular diseases. (#RESI) - Nanopath is transforming the ob/gyn experience with a platform enabling immediate and cost-effective assessment of pelvic and gynecologic conditions. (#Biotechshowcase) - Path Fertility, a "women's health adjacent" venture, is shedding light on the often overlooked male side of infertility. (Biotech showcase) - EndoCyclic Therapeutics leverages peptide insights to innovate diagnostics and therapies for endometriosis. - iSono Health is pioneering an AI-driven portable 3D ultrasound for breast cancer detection. - Applikate Technologies Inc is reimagining diagnostics for a healthier future. By advancing women's health through such groundbreaking initiatives, we not only enhance the well-being of families but also contribute to the overall health of our nation. Thank you for championing these vital causes! **Show your #pink today. #pinkJPM2025 #HealthInnovation #NIHfunded #femtech #obgyn #fertility #inferility #endometrios #breastcancer #cardiovascular #femaleheart #pelvichealth #medtech #medicaldevices NIH SEED National Heart, Lung, and Blood Institute National Cancer Institute (NCI) National Institute of Allergy and Infectious Diseases (NIAID) Eunice Kennedy Shriver?National Institute of Child Health and Human Development (NICHD)

Will you be attending next week's #BiotechShowcase? Be sure to stop by and say hello. ?? Our team is excited to meet you! Learn more about the NIH-funded companies and innovations we'll be featuring at this exciting event: https://ow.ly/jmZG50Uy7UJ Artery Therapeutics, Inc. Atom Bioworks Immuto Scientific Inherent Biosciences, Inc. DBA Path Fertility Microvascular Therapeutics Nanopath NuvOx Pharma Saros Therapeutics Cigma Cellergy Pharma National Institute on Aging (NIA) National Institute of Dental and Craniofacial Research (NIDCR) The National Institute on Drug Abuse (NIDA) National Institute of General Medical Sciences (NIGMS) National Institute of Neurological Disorders and Stroke (NINDS) National Heart, Lung, and Blood Institute National Institute of Allergy and Infectious Diseases (NIAID) National Cancer Institute (NCI) Eunice Kennedy Shriver?National Institute of Child Health and Human Development (NICHD) NINDS Small Business Programs

I’m deeply honored to share that the MassNextGen program at the Massachusetts Life Sciences Center (MLSC) has been recognized by the Cambridge Chamber of Commerce with their prestigious Visionary Award! This recognition underscores the incredible impact of MassNextGen in advancing diversity, equity, and inclusion in life sciences entrepreneurship. A heartfelt thank you to Michelle Consalvo and the team at Takeda for their partnership as a Platinum Anchor Sponsor. Your unwavering support has been instrumental in driving the success of this program and empowering underrepresented entrepreneurs to scale their businesses and innovations. I’d also like to recognize Cinar Efe Sumer for his invaluable contributions to MassNextGen's programming efforts. Lastly, congratulations to Amogha Tadimety and Alison Burklund at Nanopath, whose success as MassNextGen awardees exemplifies the program’s vision. Your accomplishments are a testament to the power of innovation and the importance of fostering a diverse entrepreneurial ecosystem. This award celebrates not just the achievements of MassNextGen but also the collective efforts of our partners, awardees, coaches and industry experts to create a more inclusive future for life sciences. We look forward to our continued partnership! #VisionaryAward #MassNextGen #LifeSciences #Innovation #DEI #Entrepreneurship #CambridgeMA

We're excited to announce that Nanopath has the opportunity to host a postdoc through the Innovative Postdoctoral Entrepreneurial Research Fellowship (I-PERF), an initiative from American Society for Engineering Education funded by the National Science Foundation (NSF). Nanopath is looking for a postdoctoral fellow to join our growing team and contribute expertise in nanoscale diagnostic sensors. If you are looking to experience an exciting year at a?high-tech startup, please create a profile and apply at the link below! The I-PERF program offers a competitive package including salary, health insurance, relocation assistance, and professional development training. If you're interested in women's health and diagnostic innovation, come join us at The Engine Accelerator in Cambridge, MA!

This week, Nanopath's Director of Engineering, Matt Cote, will be speaking at ASME IMECE. He will be discussing Nanopath's ongoing (and exciting) journey from prototype to product. If you're attending, make sure not to miss it! Wednesday (11/20) 3:15-3:30pm.

Nanopath's new website has officially gone live! Big thanks to Tributary Design Studio for all of your creativity in helping our message and vision for Nanopath come to life. Go check it out ?? www.nanopath.com

Help us give a warm welcome to our two newest team members, George Roudebush and Minal M.! Read their bios below! George is an Electromechanical Design Engineer with experience in Consumer Products and Life Science Tools. He earned his Bachelor's Degree in Mechanical Engineering and Robotics from MIT and has been doing hands on product development ever since. He's most interested in distilling complex problems into manageable technical solutions and providing users intuitive access to complex instrument capabilities. Minal is a Chemical Engineer with a penchant for biotherapeutics and biotechnology. She earned her Master’s in Chemical Engineering at Columbia University and has since been working on improving diagnostic solutions in disease detection. Her interests lie in revamping complex production processes into simplistic manufacturing solutions and improving process efficacy while enhancing product quality.

Our founders Alison Burklund and Amogha Tadimety had a chance to chat with Carina about their journey founding and building Nanopath. A key focus of the conversation was Nanopath's amazing, mission-driven team - huge thank you to all of our amazing team members!

Nanopath is thrilled to announce that we have been awarded $4M in federal funding from the The National Institutes of Health (NIH) and National Science Foundation (NSF) (NSF). This new funding comes in the form of two Phase II SBIR grants, and brings our total funds raised to over $15M. We are so excited to have the backing and support of the greater scientific community! These awards will directly support continued development of our first-in-class, point-of-care molecular diagnostic platform that is intentionally designed to meet the needs of women. Huge kudos to the entire Nanopath team for all of their hard work and dedication!